Sort   by:  
 Page size 
UnknownBeneficial Effects of Silybin Treatment After Viral Eradication in Patients With HCV-Related Advanced Chronic Liver Disease: A Pilot Study.
Not available
S-EPMC8847679 | biostudies-literature
UnknownCoffee prevents fatty liver disease induced by a high-fat diet by modulating pathways of the gut-liver axis.
Not available
S-EPMC6477661 | biostudies-literature
UnknownAnalysis of phase III clinical trials in metastatic NSCLC to assess the correlation between QoL results and survival outcomes.
Not available
S-EPMC10318754 | biostudies-literature
UnknownAnalysis of Health-Related Quality of Life Reporting in Phase III RCTs of Advanced Genitourinary Tumors.
Not available
S-EPMC10705354 | biostudies-literature
UnknownSilibinin Restores NAD⁺ Levels and Induces the SIRT1/AMPK Pathway in Non-Alcoholic Fatty Liver.
Not available
S-EPMC5691703 | biostudies-literature
UnknownHealth-related quality of life assessment in trials testing tyrosine kinase inhibitors or immune checkpoints inhibitors in early-stage NSCLC.
Not available
S-EPMC12558747 | biostudies-literature
UnknownCoffee Restores Expression of lncRNAs Involved in Steatosis and Fibrosis in a Mouse Model of NAFLD.
Not available
S-EPMC8467439 | biostudies-literature
UnknownShifting from a Biological-Agnostic Approach to a Molecular-Driven Strategy in Rare Cancers: Ewing Sarcoma Archetype.
Not available
S-EPMC10045500 | biostudies-literature
UnknownMoving Immune Checkpoint Inhibitors to Early Non-Small Cell Lung Cancer: A Narrative Review.
Not available
S-EPMC9735901 | biostudies-literature
UnknownImpact of platinum-based chemotherapy and CTLA-4 inhibition on acquired resistance to first-line anti-PD-1/PD-L1 agents in non-small cell lung cancer: a systematic review and reconstructed individual patient data analysis.
Not available
S-EPMC12441679 | biostudies-literature
Sort   by:  
 Page size